Ipek Erdogan-Trinkaus - 02 Dec 2024 Form 3 Insider Report for Eton Pharmaceuticals, Inc. (ETON)

Role
Chief Commercial Officer
Signature
/s/ Ipek Erdoga-Trinkaus
Issuer symbol
ETON
Transactions as of
02 Dec 2024
Net transactions value
$0
Form type
3
Filing time
09 Dec 2024, 17:11:06 UTC
Next filing
12 Dec 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ETON Employee Stock Option (Right to Buy) 02 Dec 2024 Common Stock 75,000 $12.46 Direct F1
holding ETON Restricted Stock Units 02 Dec 2024 Common Stock 8,026 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 (1) The Employee Stock Options and Restricted Stock Units will vest in four equal installments on December 2, 2025, 2026, 2027, and 2028.